Clinical Trials Logo

Oxygen Consumption clinical trials

View clinical trials related to Oxygen Consumption.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT06186297 Completed - Oxygen Consumption Clinical Trials

Boosting Performance: The Power of Cranberry Supplementation

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Cranberry is a fruit native to North America that is widely grown in Quebec and has been shown to have the highest antioxidant capacity among the most commonly eaten fruits. Consequently, consuming cranberries prior to exercising may help to improve exercise endurance by preventing accumulation of reactive oxygen species. For aerobic endurance, in order to maintain a certain pace for a long duration, runners need to effectively neutralize reactive oxygen species. Although it is not the only component involved in running, offsetting reactive oxygen species should improve running performance. To test this, we plan to investigate the effects, both acute and chronic, of a cranberry extract on the oxygen consumption in 18-35 year old males and females. The present research project will contribute to expand our knowledge of how cranberry extract can exert a positive effect, and thus improve aerobic performance or even every day life. This project can benefit a wide range of the population, from sedentary individuals and older adults to elite athletes by providing an all-natural supplement alternative.

NCT ID: NCT06113133 Completed - Oxygen Consumption Clinical Trials

Assessment of Maximal Oxygen Uptake in Cardiac Rehabilitation

Start date: December 1, 2022
Phase:
Study type: Observational

To advance the methodology for evaluating persons with heart disease and their maximal oxygen uptake, the primary aim of this study is to investigate the occurrence of a plateau in oxygen uptake. This plateau will be examined for the purpose of assessing VO2 max in persons enrolled in exercise-based cardiac rehabilitation. Furthermore, this study aims to investigate the age-related respiratory exchange ratio, and rating of perceived exertion, and describe their association with the presence of a plateau. Heart disease and characteristics for all participants are obtained. Participants underwent a maximal exercise test on an ergometer cycle with direct measurement of oxygen uptake to assess oxygen plateau attainment. This included measurement of the maximal oxygen uptake, respiratory exchange ratio, heart rate and the ratio of perceived exertion (BORG6-20).

NCT ID: NCT05798130 Completed - Oxygen Consumption Clinical Trials

Assessment of Oxygen Extraction Rate Changes Following Red Blood Cell Transfusion in the Intensive Care Unit

Start date: April 1, 2023
Phase:
Study type: Observational [Patient Registry]

Restrictive and liberal approaches to hemoglobin targets are used when deciding on red blood cell transfusions in patients who do not have acute bleeding and have a hemodynamically stable course in the intensive care unit. However, physiologic trigger points that assess tissue oxygenation when deciding on blood transfusion in patients are also among the important topics of study in recent years. In this study, the investigators will evaluate the oxygen extraction rate, which is an important indicator of the balance between tissue oxygen delivery and consumption. Whether oxygen extraction rate can be used as a trigger for blood transfusion will be determined by clinical outcomes in ICU patients. If physiologic transfusion targets are feasible, the risks of unnecessary transfusions can be avoided with individualized targets, and the decision to transfuse blood can be made without delay in patients requiring red blood cell transfusion.

NCT ID: NCT05090254 Completed - Oxygen Consumption Clinical Trials

The Effect of Perioperative Cardiac Output-guided GDT on Oxygen Delivery, Consumption, and Microcirculatory Perfusion

CUSTOM
Start date: August 1, 2021
Phase: N/A
Study type: Interventional

Perioperative cardiac output-guided goal-directed therapy (GDT) triggers fluid, vasopressor, and inotrope administration assuming that optimizing cardiac output (i.e., global blood flow) ensures adequate oxygen delivery and microcirculatory perfusion - that are usually not directly monitored during goal-directed therapy. There is increasing evidence that perioperative cardiac output-guided goal-directed therapy may reduce postoperative complications compared to routine hemodynamic management in high-risk patients having major surgery. The effect of cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as microcirculatory perfusion, however, is unknown. The investigators aim to investigate the effect of using different cardiac output-guided goal-directed therapy algorithms on perioperative oxygen delivery and consumption as well as sublingual microcirculatory perfusion compared to routine perioperative hemodynamic management in patients having major abdominal surgery with general anesthesia.

NCT ID: NCT04209647 Completed - Obesity Clinical Trials

A Comparison of Continuous Moderate Training and Reduced High Intensity Interval Training in Obese Young Adults

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Exercise is a key component of obesity management. Obese subjects cannot attend or sustain exercise program because of increased general fatigue, dyspnea and muscle fatigue. And they feel more exertion when comparing with normal weight subjects. Reduced-exertion high-intensity interval training (REHIT) is a alternative method to continuous exercise programs. The investigators aimed comparing metabolic effects of REHIT and continuous exercise in young adults, in this study.

NCT ID: NCT03602365 Completed - Physical Inactivity Clinical Trials

Gentle Jogger and Oxygen Consumption

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

This is a non randomized study to determine the effects of Gentle Jogger(GJ), a passive jogging device on oxygen consumption in 2 postures supine and seated. Oxygen consumption measurements will be performed via indirect calorimetry in duplicate at rest ( supine and seated posture) , and repeated in duplicate during GJ (in supine and seated posture)

NCT ID: NCT02802111 Completed - Oxygen Consumption Clinical Trials

Change in Oxygen Consumption Following Inhalation Beta Agonists in Healthy Adults

Start date: June 2015
Phase: N/A
Study type: Interventional

Albuterol is the most commonly used β agonist to treat reversible lower airway obstruction. Albuterol contains a racemic mixture of two enantiomers. Levalbuterol contains the single R form enantiomer. Levalbuterol is frequently prescribed to limit cardiovascular toxicity. The investigators sought to examine the changes in oxygen consumption (V'O2) and Heart Rate (HR) following administration of albuterol and

NCT ID: NCT02774577 Completed - Aged Clinical Trials

Oxygen Consumption After Acute Whole Body Vibration Session

Start date: June 1, 2016
Phase: N/A
Study type: Interventional

Noninvasive assessment of VO2 during a single session of whole body vibration and changes in blood flow caused by the acute activity.

NCT ID: NCT01327820 Completed - Clinical trials for Peripheral Arterial Disease

Study of Post-operative Oxygen Consumption Following Vascular Surgery

Start date: March 2011
Phase: N/A
Study type: Observational

To define any changes in whole body oxygen consumption that occur following major vascular surgery (open aortic aneurysm surgery; endovascular aortic aneurysm repair; and infra-inguinal lower limb revascularisation procedures).